Publications 2023

Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
41, 100597
DOI 10.1016/j.ctro.2023.100597, PubMed 37441544

Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
16, 1056068
DOI 10.3389/fninf.2022.1056068, PubMed 36743439

Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
50 (8), 5294
DOI 10.1002/mp.16594, PubMed 37573581

Publications 2022

Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
7 (5), 100588
DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420

Publications 2021

Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
4 (1), 33
DOI 10.1038/s41746-021-00398-4, PubMed 33619361

Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
MRI pulse sequence integration for deep-learning-based brain metastases segmentation
48 (10), 6020-6035
DOI 10.1002/mp.15136, PubMed 34405896

Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
150 (1), 100-111
DOI 10.1002/ijc.33768, PubMed 34449877

Publications 2020

Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
65 (22), 225020
DOI 10.1088/1361-6560/abb71a, PubMed 33200748

Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
Soluble AXL as a marker of disease progression and survival in melanoma
15 (1), e0227187
DOI 10.1371/journal.pone.0227187, PubMed 31917795

Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
2 (1), vdaa028
DOI 10.1093/noajnl/vdaa028, PubMed 32642687

Publications 2019

Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, Vardy JL, Nowak AK, Dhillon HM, Ahmed T, Shivalingam B, Long GV, Menzies AM, Hruby G, Drummond KJ, Mandel C, Middleton MR, Reisse CH, Paton EJ, Steel V, Williams NC, Scolyer RA, Morton RL, Thompson JF (2019)
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
37 (33), 3132-3141
DOI 10.1200/JCO.19.01414, PubMed 31553661

Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
197 (1), 74-82
DOI 10.1111/cei.13283, PubMed 30821848

Publications 2018

Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
3 (4), 559-567
DOI 10.1016/j.adro.2018.05.005, PubMed 30370356

Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
79 (1), 118-125.e1
DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861

Publications 2016

Fogarty GB, Hong A, Gondi V, Burmeister B, Jacobsen K, Lo S, Paton E, Shivalingam B, Thompson JF (2016)
Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice
16, 372
DOI 10.1186/s12885-016-2433-8, PubMed 27370683

Publications 2015

Fogarty GB, Hong A, Dolven-Jacobsen K, Reisse CH, Burmeister B, Haydu LH, Dhillon H, Steel V, Shivalingam B, Drummond K, Vardy J, Nowak A, Hruby G, Scolyer RA, Mandel C, Thompson JF (2015)
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
8, 192
DOI 10.1186/s13104-015-1153-5, PubMed 25952979

Publications 2014

Fogarty GB, Hong A, Jacobsen KD, Reisse CH, Shivalingam B, Burmeister B, Haydu LE, Paton E, Thompson JF (2014)
Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
7, 412
DOI 10.1186/1756-0500-7-412, PubMed 24981506

Hong AM, Suo C, Valenzuela M, Haydu LE, Jacobsen KD, Reisse CH, Fogarty G (2014)
Low incidence of melanoma brain metastasis in the hippocampus
111 (1), 59-62
DOI 10.1016/j.radonc.2014.01.012, PubMed 24560764

Publications 2013

Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA (2013)
Malignant melanoma--diagnosis, treatment and follow-up in Norway
133 (20), 2154-9
DOI 10.4045/tidsskr.12.1416, PubMed 24172628

Publications 2010

Jacobsen KD, Tausjø J, Hager B, Gundersen S (2010)
[Treatment of metastatic malignant melanoma localized to an extremity]
130 (1), 21-4
DOI 10.4045/tidsskr.09.0701, PubMed 20094118

Publications 2006

Jacobsen KD, Fosså SD, Aamdal S (2006)
[Malignant melanoma--diagnosis and treatment]
126 (23), 3094-7
PubMed 17160112

Publications 2004

Jacobsen KD, Hessling SE, Helsing P (2004)
Føflekkreft og annen hudkreft
In Kreftinfo, Den norske kreftforening, Oslo, 30 s.
BIBSYS 060365811

Publications 2003

Jacobsen KD (2003)
Fertility saving treatment in testicular cancer
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 105, 1 b. (flere pag.)
BIBSYS 030982391, ISBN 82-8072-070-7

Publications 2002

Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
42 (3), 229-38; discussion 237-8
DOI 10.1016/s0302-2838(02)00274-9, PubMed 12234507

Publications 2001

Jacobsen KD, Theodorsen L, Fossa SD (2001)
Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
165 (1), 93-6
DOI 10.1097/00005392-200101000-00023, PubMed 11125372

Publications 1997

Jacobsen KD, Olsen DR, Fosså K, Fosså SD (1997)
External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
38 (1), 95-102
DOI 10.1016/s0360-3016(96)00597-4, PubMed 9212009

Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
193 (7), 471-8
DOI 10.1016/s0344-0338(97)80099-4, PubMed 9342752